Sorrento Therapeutics, Inc.
SRNE
Revenue
13.03M
▲7.26M▲125.58%
3 Months ChangeAssets
456.69M
▼-3.37M▼-0.7327%
3 Months ChangeLiabilities
654.65M
▲67.17M▲11.43%
3 Months ChangeFree Cash Flow
-49.55M
▲36.41M▲42.36%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2023-11-07
Form 8-K
ID: 0001104659-23-115270
2023-11-03
Form 8-K
ID: 0001104659-23-114354
2023-10-27
Form 8-K
ID: 0001104659-23-112178
2023-10-05
Form 8-K
ID: 0001104659-23-107275
2023-09-26
Form 8-K
ID: 0001104659-23-103911
2023-09-13
Form 8-K
ID: 0001104659-23-100179
2023-08-28
Form 8-K
ID: 0001104659-23-096071
2023-08-21
Form 8-K
ID: 0001104659-23-093768
2023-08-14
Form 10-Q
ID: 0000950170-23-041995
2023-08-10
Form 8-K
ID: 0001104659-23-089802